✦ LIBER ✦
Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial
✍ Scribed by Dispenzieri, A; Jacobus, S; Vesole, D H; Callandar, N; Fonseca, R; Greipp, P R
- Book ID
- 109887167
- Publisher
- Nature Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 327 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.